Network Synergy Group Company Profile

20:53 EDT 20th June 2018 | BioPortfolio

Network Synergy Group, a wholly-owned subsidiary of GENEX Services, Inc., is a national physical therapy management company founded in 1997. The company offers a comprehensive and outcome-based approach to managing workers’ compensation physical therapy claims. The company’s goal is to ensure greater accountability, more collaboration and communication among providers, file managers and injured workers, and to deliver lower costs and superior results. For more information visit or call 813-207-0727.

News Articles [941 Associated News Articles listed on BioPortfolio]

Cisco Systems, Inc.: China Unicom Teams with Cisco to Enable Cloud + Network Synergy with Segment Routing

BEIJING, April 17, 2018 (GLOBE NEWSWIRE) -- Recently, China United Network Communications Group Co., Ltd. (China Unicom) officially announced seven new products: Cloud Network Connection, Cloud Ne...

In The Spotlight: Synergy Pharma

For Synergy Pharmaceuticals Inc. (SGYP), whose shares are down 11% year-to-date, the worst may be behind it. With Synergy Pharma taking all steps to effectively manage costs while simultaneously inves...

Synergy's therapy for IBS with constipation approved by FDA

Synergy Pharmaceuticals was granted approval by the FDA for its once-daily Trulance, or plecanatide, as a treatment for adult -More- 

Activist Group Strikes Down Key Proposals At Synergy Pharma

Synergy Pharmaceuticals: Activist Group Reaches 20.6 Million Shares

Pomerantz LLP: SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP

NEW YORK, NY / ACCESSWIRE / March 8, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against Synergy Pharmaceuticals Inc. ("Synergy" or the "Company") (NASDAQ: SGYP) and ...

Investor Alert: Kaplan Fox Announces Investigation Of Synergy Pharmaceuticals Inc.

Synergy is a biopharmaceutical company focused on the development and commercialization of therapies to treat gastrointestinal disorders and diseases.  On September 5, 2017, the Read more...

Synergy Pharmaceuticals to Present at Oppenheimer 28th Annual Healthcare Conference

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) today announced that Troy Hamilton, Chief Executive Officer of Synergy, will present a corporate update at the Oppenheimer 28th Annual...

PubMed Articles [3218 Associated PubMed Articles listed on BioPortfolio]

Adaptation of kinematic synergy and postural control to mechanical ankle constraint on an unsteady stance surface.

Joint constraint interferes with the coordinative structure in joint movements used to optimize postural stability. This study aimed to investigate changes in postural synergy when the ankle joints we...

Bioabsorbable polymer everolimus-eluting stents in patients with acute myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry.

The clinical performance of the SYNERGY drug-eluting stent (DES) in patients with acute myocardial infarction (MI) has not been investigated in detail. We sought to report on the outcomes after SYNERG...

Brain network alteration in patients with temporal lobe epilepsy with cognitive impairment.

The aims of this study were to investigate the brain network alternation in patients with temporal lobe epilepsy (TLE) with and without cognitive impairment (CI) using functional magnetic resonance im...

Consistency of fish-shoal social network structure under laboratory conditions.

We investigated the consistency of association network structure for groups of sticklebacks Gasterosteus aculeatus. Each group was observed twice and we varied the duration between observations and th...

Muscle Synergy-Driven Robust Motion Control.

Humans are able to robustly maintain desired motion and posture under dynamically changing circumstances, including novel conditions. To accomplish this, the brain needs to optimize the synergistic co...

Clinical Trials [4407 Associated Clinical Trials listed on BioPortfolio]

A 2x2 Factorial Randomized Controlled Trial of Colchicine and Spironolactone in Patients With STEMI Who Have Undergone PCI With SYNERGY Stent Registry

The CLEAR SYNERGY trial will study the long term effects of three multidisciplinary treatments following PCI to treat ST elevation myocardial infarction. These treatments address both the ...

Strut Coverage With SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction

To assess strut coverage in patients presenting an acute myocardial infarction and treated either with the SYNERGY stent or the Bioresorbable Vascular Scaffold, through a parallel group de...

IRIS-Synergy Cohort in the IRIS-DES Registry

The purpose of this study is to evaluate the relative effectiveness and safety of Synergy stent compared to other drug eluting stents.

Safety and Performance Evaluation of CircuLite Synergy

The purpose of the study is to demonstrate the safety and functionality of the CircuLite Synergy Pocket Circulatory Assist Device.

Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer

The lack of non-overlapping toxicities between the two drugs, the ease of all oral drug administration, and the possibility for antitumor synergy make exploration of this combination regim...

Companies [2304 Associated Companies listed on BioPortfolio]

Network Synergy Group

Network Synergy Group, a wholly-owned subsidiary of GENEX Services, Inc., is a national physical therapy management company founded in 1997. The company offers a comprehensive and...

Synergy Health Concepts

The team at Pacific Interventionalists launched Synergy Health Concepts to focus specifically on CCSVI treatment and care. Chronic Cerebro-Spinal Venous Insufficiency (CCSVI) is c...

Synergy Strips Corp.

Synergy Strips Corp. (OTCQB:SNYR) is a consumer health care company, that is in the process of building a portfolio of best-in- class consumer product brands. Synergy's strategy i...

Synergy Pharmaceuticals, Inc.

Synergy is a biopharmaceutical company focused on the development of new drugs to treat gastrointestinal disorders and diseases. Synergy's proprietary drug SP-304 is a synthetic a...

Synergy Research Inc.

Synergy Research was found in 1997. It is a privately held company. Centrally located in Northern New Jersey. Synergy Research is all about bringing together the necessary talent and resources, combin...

More Information about "Network Synergy Group" on BioPortfolio

We have published hundreds of Network Synergy Group news stories on BioPortfolio along with dozens of Network Synergy Group Clinical Trials and PubMed Articles about Network Synergy Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Network Synergy Group Companies in our database. You can also find out about relevant Network Synergy Group Drugs and Medications on this site too.

Quick Search


Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Corporate Database Quicklinks

Searches Linking to this Company Record